Accession Number: | 0001209191-21-021817 |
Date: | 2021-03-16 |
Issuer: | MARKER THERAPEUTICS, INC. (MRKR) |
Original Submission Date: |
SONSINI PETER W.
2855 SAND HILL ROAD
MENLO PARK, CA 94025
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-03-16 | P | 5,714,285 | a | $1.75 | 10,714,285 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the reporting person is a manager of nea 16 gp, llc, which is the sole general partner of nea partners 16, l.p. ("nea partners 16"). nea partners 16 is the sole general partner of new enterprise associates 16, l.p. ("nea 16"), which is the direct beneficial owner of the shares. the reporting person disclaims beneficial ownership within the meaning of section 16 of the securities exchange act of 1934, as amended, or otherwise of such portion of the shares held by nea 16 in which the reporting person has no pecuniary interest. |